Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study

por Odutola, A, Ota, MO, Ogundare, EO, Antonio, M, Owiafe, P, Worwui, A, Greenwood, B, Alderson, M, Traskine, M, Verlant, V, Dobbelaere, K, Borys, D
Publicado 2015